Study Name:
LUNAR: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapies for treatment of stage 4 non-small cell lung cancer (NSCLC) following platinum failure.
Targeted Disease(s):
Lung Cancer
Purpose of Study:
To test the efficacy and safety of TTFields, using the NovoTTF-100L system, concurrent with standard therapies for stage 4 NSCLC patients, following progression while on or after platinum based treatment.
Study Dates:
December 1, 2016 - September 30, 2023
Study Location:
FL
Lead Institution:
BRCR medical center
Funding Source:
Novocure
ClinicalTrails.gov Identifier:
NCT02973789
Contact:
Victoria Reyes
Contact Phone: 561-447-0614
Contact Email: [email protected]
